Article

Non-Hodgkin's lymphoma involving the gynecologic tract: a review of 88 cases.

Department of Pathology, The University of Texas-Houston Medical School, USA.
Advances in Anatomic Pathology (Impact Factor: 3.1). 08/2001; 8(4):200-17. DOI: 10.1097/00125480-200107000-00002
Source: PubMed

ABSTRACT Non-Hodgkin's lymphoma (NHL) involving the gynecologic tract is unusual and may cause confusion for the pathologist not familiar with its clinical and histologic features. The literature regarding this topic is also confusing, as modern NHL classification systems were not used or patients were not staged according to the Ann Arbor system in many prior reports. In addition, immunophenotypic data is not available for many cases, particularly in older studies. In the past year, there has been an interest in NHL involving the gynecologic tract and 88 cases have been collected. These cases were reviewed in the Pathology Department of M.D. Anderson Cancer Center during the past two decades, and many of these patients were treated at this hospital. In this review, these cases are reported using updated terminology and almost all cases were immunophenotyped using immunohistochemical methods or flow cytometric methods in a small subset of cases. These cases have also been segregated into two groups: 1) localized NHL, that presumably initially arose in the gynecologic tract and therefore are primary; and 2) NHL that involved the gynecologic tract as a part of systemic disease, and therefore most likely represent secondary involvement of the gynecologic tract. The differential diagnosis of NHL involving gynecologic organs is discussed.

1 Follower
 · 
96 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Indolent extranodal T-cell lymphoproliferative disorders have recently been described as new entities in the gastrointestinal tract and acral sites displaying clonal T-cell receptor (TCR) rearrangement and nonactivated cytotoxic CD8+ T-cell phenotypes. Methods/Results: We report a unique case of an atypical myometrial T-cell lymphoproliferation in a 39-year-old multiparous woman, which shares many of the features mentioned above: CD8+/TIA1+/granzyme B- phenotype, clonal TCR rearrangement and indolent course. Conclusion(s): We hypothesize that it might derive from a subset of uterine nonrecirculating CD8+ resident memory T cells expanded after repeated exposure to allo-extravillous trophoblastic antigen. © 2014 S. Karger AG, Basel.
    Pathobiology 08/2014; 81(4):176-182. DOI:10.1159/000363346 · 2.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Primary ovarian lymphoma is rare. To better understand the clinicopathological and molecular features of these tumours, we studied 14 patients (age range 13 to 74 years, mean 46.9 years) with non-Hodgkin's lymphoma who initially presented with an ovarian tumour. The clinicopathological features were reviewed and tissue samples were studied by immunohistochemistry and for immunoglobulin gene rearrangement, presence of Epstein Barr virus and for MYC and BCL-2 rearrangements by fluorescence in situ hybridisation. The most common symptoms were abdominal pain and abdominal distension. Ten patients had a unilateral (7 left, 3 right) ovarian mass and 4 had bilateral ovarian masses, size range 4 to 13 cm (mean, 7.9 cm). Of the 14 lymphomas, 12 were classified as diffuse large B-cell lymphoma (DLBCL) and 2 as Burkitt lymphoma. The Burkitt lymphomas had a MYC rearrangement. The DLBCLs were of the germinal centre B-cell-like subtype. One DLBCL patient had MYC and BCL2 rearrangements. The treatment consisted of various combinations of surgery, chemotherapy and radiotherapy. The follow-up period ranged from 3 to 56 months. During the follow-up period, 8 patients died of disease, 4 were alive with disease, and 2 were alive without disease. Most primary ovarian lymphomas are of germinal centre B-cell-like subtype DLBCL, which have high proliferative activity and poor prognosis.
    Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 11/2014; 466(1). DOI:10.1007/s00428-014-1682-7 · 2.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The relative frequency of ovarian tumors and tumor-like lesions that are found in young females (defined in this essay as up to 30 years of age) differs considerably from that seen in older patients. The entire spectrum of lesions that may be encountered is reviewed, with emphasis on those disproportionately seen in younger patients, particularly primitive germ cell tumors, certain tumors in the sex cord-stromal family, the distinctive tumor known as small cell carcinoma of hypercalcemic type, and selected tumor-like lesions. Comments are made initially on the relative frequency of the various well known categories of ovarian neoplasia in the first three decades, compared to females overall, and differences in the first three decades themselves are noted. Some of the more noteworthy of these include the occurrence of follicular cysts in neonates due to in-utero maternal stimulation, and the often large size of these lesions, with sometimes dramatic clinical manifestations; the relative rarity of the commonest germ cell tumor of the ovary, the dermoid cyst, in the very early years of life; the peak incidence of all primitive germ cell tumors in the mid to late teens and early twenties; the peak of small cell carcinoma of hypercalcemic type in the early twenties; the preponderance for the juvenile granulosa cell tumor to occur in the first two decades, and for one distinctive form of Sertoli-Leydig cell tumor, the retiform variant, to peak at about fifteen years of age; the occasional finding of mucinous cystic tumors, usually benign, in the teenage years, and their greater frequency than other surface epithelial neoplasms; a gradual increase in frequency of all types of surface epithelial neoplasia, but particularly mucinous tumors and serous tumors as patients move through the twenties; the rarity of metastatic neoplasia in the first three decades in general, but with occasional dramatic examples such as some Krukenberg tumors being seen in these years, as may some of the distinctive tumors of the young such as the neuroblastoma. Consideration of the gross and microscopic features, and differential diagnosis, of individual neoplasms follows the introductory remarks and emphasizes the occasional great importance of gross pathology. One example of the latter is the marked difference in most cases between the gross characteristics of a dermoid cyst and an immature teratoma, the former being dominantly cystic and the latter solid and cystic, and the latter on average being twice as large as the former. Caution should be used in entertaining a diagnosis of immature teratoma in a lesion that is grossly a typical dermoid cyst. The treacherous shared gross characteristics and age distribution of the dysgerminoma and small cell carcinoma of hypercalcemic type are noted. The rarity of monodermal teratomas and malignant neoplasms such as squamous cell carcinoma arising in dermoid cysts, in the first three decades, is noted. The distinctive features of two recently described stromal neoplasms, microcystic stromal tumor and luteinized thecomas of the type associated with sclerosing peritonitis, are emphasized. So also is the varied differential diagnosis of the juvenile granulosa cell tumor and Sertoli-Leydig cell tumor including retiform and heterologous variants. Sections on issues associated with ovarian tumors and tumor-like lesions in pregnant patients, and tumor-like lesions overall conclude the essay.
    Seminars in Diagnostic Pathology 08/2014; 31(5). DOI:10.1053/j.semdp.2014.08.001 · 1.80 Impact Factor